[ad_1]
Of: TT
Published:
Photograph: Zsolt Czegledi / AP / TT
Remdesivir’s efficacy in treating COVID-19 is discussed, but now the antiviral drug is approved for use in both the EU and the US.
The United States Food and Drug Administration (FDA) approves the drug Remdesivir for the treatment of hospitalized patients with COVID-19.
The antiviral drug Remdesivir will be the first to be approved for the treatment of COVID-19 patients in the United States, after the country’s pharmaceutical authority gave the green light.
The Gilead company, which is behind the drug, has significantly increased production to meet global demand for the drug. Remdesivir has previously been used in US healthcare during an emergency, and was used, among other things, to treat President Donald Trump when he fell ill with covid-19.
Remdesivir was approved this summer by the European Medicines Agency for use in certain seriously ill patients, following studies showing that hospital stays were shortened in patients treated with the drug.
But the picture is not clear. Last week, the WHO reported on a major international study that showed the drug does not have a significant effect on patients’ hospital stays or chances of survival.
Published:
